Synodor Pharmaceuticals Private Limited
About Synodor Pharmaceuticals Private Limited
Data last updated:
Synodor Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC354140.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Parvez Khan Saleem Khan Pathan and Pathan.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 4/P Gut No.27 Ward B – 5 Malmatta Naregaon, Aurangabad, Maharashtra, India – 431122.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.27 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net loss of ₹1.27 Lakh (net margin -99.6%) and EBITDA of -₹1.27 Lakh (EBITDA margin -99.6%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years.
Company details
Contact details
Synodor Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressH. No. 4/P Gut No.27 Ward B – 5 Malmatta Naregaon, Aurangabad, Maharashtra, India – 431122
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Synodor Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synodor Pharmaceuticals is other service activities. In detail, this covers activities of membership organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| S | Other service activities | 94 | Activities of membership organizations |
To see the full business activity and turnover split of Synodor Pharmaceuticals Private Limited, buy the company report.
Financials of Synodor Pharmaceuticals Private Limited
FY 2025 filings availableSynodor Pharmaceuticals Private Limited reported revenue of ₹1.27 Lakh (down 45% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 23% over three years, including a 45% fall in the latest year. EBITDA fell 914% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -99.6% | ||||
| Net Profit Margin | -99.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synodor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Synodor Pharmaceuticals Private Limited
Synodor Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parvez Khan Saleem Khan Pathan | Director | 27 Jan 2021 | 5 Years 8 Months | Current |
| Pathan | Director | 27 Jan 2021 | 5 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Synodor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synodor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Synodor Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
No GST registration is on our record for Synodor Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Synodor Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Parvez Khan Saleem Khan Pathan was appointed as Director on 27 Jan 2021.
Frequently asked questions
Synodor Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 January 2021 (5+ years old) and is registered under CIN U24290MH2021PTC354140.
Synodor Pharmaceuticals has 2 current directors:
- Parvez Khan Saleem Khan Pathan - Director
- Pathan - Director
The latest financial statements of Synodor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Synodor Pharmaceuticals is U24290MH2021PTC354140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synodor Pharmaceuticals was incorporated on 27 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Parvez Khan Saleem Khan Pathan was appointed as Director on 27 Jan 2021. Pathan was appointed as Director on 27 Jan 2021.
The registered office of Synodor Pharmaceuticals is at H. No. 4P Gut No.27 Ward B – 5 Malmatta Naregaon, Aurangabad, Maharashtra, India – 431122.
Synodor Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Synodor Pharmaceuticals can be reached at its registered office: H. No. 4P Gut No.27 Ward B – 5 Malmatta Naregaon, Aurangabad, Maharashtra, India – 431122.
Synodor Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.